TREATMENT OF CONDITIONS INVOLVING DEMYELINATION

Methods of treating Kawasaki disease using IL-1beta antibodies

ANTI-CXCL13 ANTIBODIES AND ASSOCIATED EPITOPE SEQUENCES

Caninized anti-NGF antibodies and their use

Antibodies against TM4SF5 and methods of use thereof

Monoclonal antibodies to anthrax protective antigen

Crosslinking of CD22 by epratuzumab triggers BCR signaling and caspase-dependent apoptosis in hematopoietic cancer cells

Humanized Anti-Factor D Antibodies And Uses Thereof

Anti c-Met antibodies

Anti c-Met antibodies

Antibodies specific for CLL-1

Bispecific antibodies against CD3 and BCMA

Human CGRP receptor binding proteins

Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

FGFR1 agonists and methods of use

Anti-CD83 antibodies and use thereof

Anti-NTB-A antibodies and related compositions and methods

Dual PDGF/VEGF antagonists

Human antibodies to serum resistance-associated protein from trypanosoma brucei rhodesiense

HUMAN ANTIBODIES TO HUMAN DELTA LIKE LIGAND 4

ANTIBODY COMPOSITIONS AND METHODS OF USE

Methods for producing antibodies

ANTIBODIES AGAINST EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) AND USES THEREOF

HIGHLY GALACTOSYLATED ANTI-HER2 ANTIBODIES AND USES THEREOF

Multispecific constructs

Method for the selection of antibodies against BCMA

Anti-GITR antibodies and methods of use thereof

Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

Antibodies against epidermal growth factor receptor (EGFR) and uses thereof

Antibody constructs for CDH19 and CD3

POLYPEPTIDES AND ANTIBODIES DERIVED FROM CHRONIC LYMPHOCYTIC LEUKEMIA CELLS AND USES THEREOF

Human monoclonal antibodies specific for glypican-3 and use thereof

Interferon α and ω antibody antagonists

Anti-IL-6 antibodies for the treatment of oral mucositis

IL-31 monoclonal antibodies

Highly galactosylated anti-TNF-α antibodies and uses thereof

Anti-semaphorin 3A antibody and treatment of Alzheimer's disease and inflammatory immune diseases using same

Compositions and methods related to antibodies that neutralize coagulase activity during disease

Full spectrum anti-dengue antibody

Anti-TAT226 antibodies and immunoconjugates

Antibody-drug conjugates and uses thereof

Monoclonal antibodies against HER2 epitope and methods of use thereof

Anti-wall teichoic antibodies and conjugates

Methods for expansion or depletion of T-regulatory cells

Compositions and methods for growth factor modulation

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of P38 multi-tRNA synthetase complex

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of glutaminyl-tRNA synthetases

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of Valyl-tRNA synthetases

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of phenylalanyl-alpha-tRNA synthetases

Soluble human ST-2 antibodies and assays

Nucleic acids encoding immunoglobulins that bind TGF-beta receptor II

Compositions and methods for growth factor modulation

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

ANTIBODIES DIRECTED AGAINST PYROGLUTAMATE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1 N1PE)

Dipeptide-repeat proteins as therapeutic target in neurodegenerative diseases with hexanucleotide repeat expansion

Humanized anti-HMGB1 antibody or antigen-binding fragment thereof

Composition of anti-ENDO180 antibodies and methods of use for the treatment of cancer and fibrotic diseases

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of tyrosyl-trna synthetases

Tissue plasminogen activator antibodies and methods of use

Human monoclonal antibodies to ganglioside GD2

METHODS FOR IMPROVING SAFETY OF BLOOD-BRAIN BARRIER TRANSPORT

Humanized monoclonal antibodies against the extracellular domain of human death receptor 5

Antibodies against glucocorticoid-induced tumor necrosis factor receptor (GITR) and uses thereof

Humanized pertussis antibodies and uses thereof

Antagonists of IL-6 to prevent or treat thrombosis

Immunoassay for synthetic cannabinoids of the adamantyl indazole/indole-3-carboxamide family

PD-L1 antibodies and uses thereof

Anti-HER2 glycoantibodies and uses thereof

BCMA antigen binding proteins

Human anti TSHR antibodies

Human Monoclonal Antibodies Against Human Chemokine Receptor CCR7

Antibody targeting osteoclast-related protein siglec-15

HUMAN ANTI-KIR ANTIBODIES

Antibody binding specifically to human and mouse L1CAM protein, and use therefor

DUAL SPECIFIC BINDING PROTEINS DIRECTED AGAINST IL-13 AND/OR IL-17

ANTIBODIES TO GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR

Viral Inactivation During Purification of Antibodies

Formulation of human antibodies for treating TNF-alpha associated disorders

Formulation of human antibodies for treating TNF-alpha associated disorders

Formulation of human antibodies for treating TNF-alpha associated disorders

Formulation of human antibodies for treating TNF-alpha associated disorders

Anti-TNF-alpha glycoantibodies and uses thereof

Human anti-tau antibodies

Compositions and methods for treatment and detection of cancers

Compositions and methods for treating and preventing infections

Monoclonal antibody against muramyl peptides

Compositions and methods relating to universal glycoforms for enhanced antibody efficacy

Class I anti-CEA antibodies and uses thereof

Anti-EphA2 antibodies and methods of use thereof

Formulation of human antibodies for treating TNF-alpha associated disorders

Heroin Haptens, Immunoconjugates and Related Uses

Compositions and methods for immunotherapy

Diagnostic method for determining the presence and amount of human interleukin-3 in a sample using novel IL-3 antibodies

Anti-tofacitinib antibodies and uses thereof for drug monitoring

Antibody Fc mutants with ablated effector functions

TEM-1 diagnostic antibodies

Inert format

Anti-CD324 monoclonal antibodies and uses thereof

Antibodies that bind human CD27 and uses thereof

Human antibodies to the glucagon receptor and methods of use thereof

Anti-EGFR antibodies and uses thereof

Anti-EGFR antibodies and antibody drug conjugates

MAC-1 ANTIBODIES AND USES THEREOF

Human monoclonal antibodies to programmed death ligand 1 (PD-L1)

Antibodies to IL-6 and use thereof

Compositions and methods for growth factor modulation

Humanized or affinity-matured anti Ang-2 antibody and uses thereof

Antagonist antibodies against GDF-8 and uses therefor

BIOMARKER METHODS AND COMPOSITIONS

Human antibodies to middle east respiratory syndrome—coronavirus spike protein

Chemically modified targeting protein and use thereof

Animal models and therapeutic molecules

Anti-complement C1s antibodies and methods of inhibiting complement C1s activity

Monoclonal antibodies against c-Met

DEPLETION OF IL23R EXPRESSING CELLS IN THE TREATMENT OF VARIOUS DISEASES

Low affinity blood brain barrier receptor antibodies and uses therefor

Antibodies to TNFα

Ang2 antibodies

VEGFR2/Ang2 compounds

Anti-DLL3 antibody drug conjugates

Antibodies against and methods for producing vaccines for respiratory syncytial virus

Anti-human IgG1 antibody

Anti-SOD1 antibodies and uses thereof

NOTUM PROTEIN MODULATORS AND METHODS OF USE

Anti-cMet/anti-EGFR/anti-HER3 multispecific antibodies and use thereof

Anti-factor XI monoclonal antibodies and methods of use thereof

Anti-HER2 antibody and anti-c-Met/anti-HER2 bispecific antibodies comprising the same

Modulators

HLA-RESTRICTED, PEPTIDE-SPECIFIC BINDING PROTEINS

Antibodies targeting CDH19 for melanoma

Methods of using IL-1β compounds to treat familial mediterranean fever (FMF)

Methods of treating an IL-17A mediated pathological condition

TGF-beta-specific antibodies and methods of use thereof for treatment

Therapeutic use of antibodies to HGF

Antibodies that Bind Myostatin, Compositions and Methods

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

MDR specific antibody

HUMAN ANTIBODY SPECIFIC TO HUMAN METAPNEUMOVIRUS, OR ANTIGEN-BINDING FRAGMENT THEREOF

IL-17A binding molecules and medical uses thereof

ANTIBODY DRUG CONJUGATES

FORMULATIONS AND METHODS OF TREATING ALZHEIMER'S DISEASE AND OTHER PROTEINOPATHIES BY COMBINATION THERAPY

Methods and compositions related to modulators of eukaryotic cells

Dual targeting

Anti-PTK7 antibody-drug conjugates

Multispecific antibodies

Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof

OPTIMIZED Fc VARIANTS

DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

ANTI-CD40 ANTIBODIES

ANTIBODIES THAT BIND MEMBRANE-BOUND IL1RAP

Anti-Glypican-3 Antibody Having Improved Kinetics in Plasma

Dual-target antibody targeting VEGFR-2 and DLL4, and pharmaceutical composition including same

Anti-human B7-H4 antibodies and their uses

Anti-PD1 antibodies and their use as therapeutics and diagnostics

Methods of treating an IL-17A mediated pathological condition

Anti-human VEGF antibodies with unusually strong binding affinity to human VEGF-A and cross reactivity to human VEGF-B

A METHOD OF REDUCING BRAIN AMYLOID PLAQUES USING ANTI-AB ANTIBODIES

Anti-CD79B antibodies and immunoconjugates and methods of use

Bispecific antibodies that bind to CD38 and CD3

Single-domain antigen-binding proteins that bind mammalian IgG

Anti-OX40 antibodies and methods of use

Humanized anti-interleukin 3 receptor alpha chain antibodies

Biological materials related to c-Met

OPTIMIZATION OF ANTIBODIES THAT BIND LYMPHOCYTE ACTIVATION GENE-3 (LAG-3), AND USES THEREOF

Methods of treating chronic pain

Anti-polyubiquitin antibodies and methods of use

Anti-PHF-tau antibodies and their uses

ANTI-NPY AND PYY ANTIBODIES AND USES THEREOF

Anti-campylobacter jejuni antibodies and uses therefor

Engineered immunoglobulin heavy chain-light chain pairs and uses thereof

Compositions and methods for the display of proteins on the surface of bacteria and their derived vesicles and uses thereof

Nucleic acid molecules encoding antibody drug conjugates (ADC) that bind to 191P4D12 proteins

Antibody-SN-38 immunoconjugates with a CL2A linker

Immuno-based retargeted endopeptidase activity assays

Bi-specific antigen-binding polypeptides

Nucleic acid molecules encoding anti-CD27 antibodies

Methods and compositions for increasing α-L-iduronidase activity in the CNS

Amino acid sequences directed against cellular receptors for viruses and bacteria

Fully human antibodies and fragments recognizing human c-Met

Anti-blood dendritic cell antigen 2 antibodies and uses thereof

ASGPR antibodies and uses thereof

ANTIGEN-BINDING MOLECULE FOR PROMOTING CLEARANCE FROM PLASMA OF ANTIGEN COMPRISING SUGER CHAIN RECEPTOR-BINDING DOMAIN

Antibodies against 6-sulfo-LacNac-positive human dendritic cells, and their use

Anti-VEGF antibodies and their uses

Nucleic acids encoding anti-C5 antibodies having improved pharmacokinetics

Human antibodies to fel d1 and methods of use thereof

Antibodies to amyloid beta

FcgammaRIIB-specific Fc region variant

Binding proteins comprising at least two repeat domains against HER2

Antibody and antibody composition production method

Conjugated anti-CD38 antibodies

Antibody capable of specifically recognizing transferrin receptor

KIR3DL2 binding agents

Methods of using anti-CGRP antagonist antibodies

Aglycosylated anti-properdin antibodies

Antibodies to surface determinants

Hepatitis C virus neutralizing antibodies and methods

Antibodies against

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of methionyl-tRNA synthetasis

Therapeutic uses of anti-PCSK9 antibodies

Human LCAT Antigen Binding Proteins and Their Use in Therapy

Antibody that binds CD269 (BCMA) suitable for use in the treatment of plasma cell diseases such as multiple myeloma and autoimmune diseases

Human anti-VEGFR-2/KDR antibodies

Bispecific HER2 ligands for cancer therapy

CD33 binding agents

ANTIBODY VARIANTS

Combination of anti-KIR and anti-CTLA-4 antibodies to treat cancer

Compositions and methods for treatment of diabetic macular edema

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

Human monoclonal anti-PD-L1 antibodies and methods of use

Recombinant bispecific antibody binding to CD20 and CD95

DAC HYP compositions and methods

Antibodies against human CSF-1R and uses thereof

Antibodies against human CSF-1R and uses thereof

Compositions and methods relating to anti-IGF-1 receptor antibodies

Human anti-human epidermal growth factor receptor antibody and encoding gene and application thereof

Recombinant TNF ligand family member polypeptides with antibody binding domain and uses therefor

Method of improving patient survivability and quality of life by administering an anti-IL-6 antibody

Stable and soluble antibodies inhibiting VEGF

Broadly-neutralizing anti-HIV antibodies

Human binding molecules capable of neutralizing influenza A viruses of phylogenetic group 1 and phylogenetic group 2 and influenza B viruses

Antibody constant region variant

Anti-IL-6 antibody for use in the treatment of cachexia

RNA-specific binding antibody

ANTIBODIES WITH pH DEPENDENT ANTIGEN BINDING

Anti P2Xreceptor antibodies and fragments thereof

SUPERIOR EFFICACY OF CD37 ANTIBODIES IN CLL BLOOD SAMPLES

Methods and antibody compositions for tumor treatment

Antibodies to CD70

Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates

Antibodies with engineered IgG Fc domains

Anti-prokineticin receptor (PROKR) antibodies and uses thereof

DC-STAMP antibodies

IL-21 antibodies and methods of making or using the antibodies

Anti-C5a binding moieties with high blocking activity

Antagonist antibodies directed against calcitonin gene-related peptide and methods using same

Polypeptides specifically binding to IL-23

Antibodies, kit and method for detecting amyloid beta oligomers

Anti-complement C1s antibodies and methods of inhibiting complement C1s activity

Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof

ANTI-MESOTHELIN ANTIBODIES AND USES THEREOF

CD20-binding proteins comprising Shiga toxin A subunit effector regions for inducing cellular internalization and methods using same

GITR antibodies and methods of inducing or enhancing an immune response

Human monoclonal antibodies against CD25

Anti-EGFRvIII antibodies and uses thereof

Monoclonal antibodies for enhancing or inhibiting insulin-like growth factor 1 (IGF-1)

Anti-MCAM Antibodies and Associated Methods of Use

Method to treat migraines using CGRP antibodies

Anti-ACTH antibodies and use thereof

Expression vectors containing isolated nucleic acids encoding anti-human IL-6 antibody

Nucleic acid encoding anti-IL13 human antibodies

Anti-Laminin4 antibodies specific for LG4-5

ANTIBODIES RECOGNIZING ALPHA-SYNUCLEIN

HUMAN ANTIBODY SPECIFIC TO TOXIN PRODUCED FROM CLOSTRIDIUM DIFFICILE, OR ANTIGEN-BINDING FRAGMENT THEREOF

Method of treating cancer by administering EGFR and EGFR/IGFIR binding molecules

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of aspartyl-tRNA synthetases

Multi-specific monoclonal antibodies

Mesothelin domain-specific monoclonal antibodies and use thereof

Anti-Jagged1 antibodies and methods of use

Antibody modulators of APLNR

Human anti-tau antibodies

High affinity human antibodies to human cytomegalovirus (CMV) GB protein

TRANSGENIC MAMMALS HAVING HUMAN IG LOCI INCLUDING PLURAL VH AND VK REGIONS AND ANTIBODIES PRODUCED THEREFROM

Histidine engineered light chain antibodies and genetically modified non-human animals for generating the same

Human domain antibodies against components of the human insulin-like growth factor (IGF) system

Antibodies that specifically bind to DRG11-responsive (DRAGON) proteins

Immunoparticles and methods of generating and using same

Methods for treating cancer with nanoparticle complexes of albumin-bound paclitaxel and anti-VEGF antibodies

Innovative discovery of therapeutic, diagnostic, and antibody compositions related to protein fragments of isoleucyl tRNA synthetases

Anti-presepsin antibody

Internalizing ErbB2 antibodies

Method for treating a CX3CR1-associated disease with CX3CR1-binding polypeptides

TUMOR THERAPY WITH AN ANTI-VEGF ANTIBODY

Antibodies that specifically bind to DRG11-responsive (DRAGON) proteins

Methods of treating a tauopathy

Anti-theophylline antibodies and methods of use

Anti-EGFR/anti-HER2 bispecific antibodies with anti-EGFR DARPins

Antibodies and vaccines for use in treating ROR1 cancers and inhibiting metastasis

Fc variants with increased affinity for FcyRIIc

Mutated humanized 12G4 antibodies and the fragments thereof against the human anti-Mullerian hormone receptor type II

DUAL VARIABLE DOMAIN IMMUNOGLOBULINS AND USES THEREOF

Anti-VEGF antibodies

Combination therapy with an anti-ANG2 antibody and a CD40 agonist

Anti-PDGF-C antibodies

ANALYSIS OF UBIQUITNATED POLYPEPTIDES

Inducible coexpression system

ANTIGEN-BINDING MOLECULE AND USES THEREOF

Antibody molecules to dengue virus and uses thereof

Method for identifying compounds of therapeutic interest

Methods of Treating Pediatric Acute Lymphoblastic Leukemia with an Anti-CD22 Immunotoxin

CD27L antigen binding proteins

Antibodies to non-functional oligomeric P2X7 receptors and methods of use thereof

Single variable domain antibodies against OX40L, constructs and therapeutic use

Binding molecules to the human OX40 receptor

Bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1

Anti-CD16 binding molecules

Methods of treatment using antibodies which bind IL-17A and IL-17F

Use of antibodies for detection of IL-10

Anti-BAFF antibodies